Company intelligence / Profile preview

Novatein Biosciences

Woburn, Massachusetts, United States

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Novatein Biosciences provides a broad range of high-quality research reagents (recombinant proteins, antibodies, ELISA kits) and services supporting protein expression, purification, assay development, and biomarker discovery across disease areas including oncology, immunology, infectious disease, and metabolic disorders; their tools contribute to drug discovery and diagnostics research.

Therapeutic areas: Oncology
Modalities: Recombinant proteinAntibodyPeptideELISA kit
Industry: Drug Discovery Services

Partnerships

None widely disclosed; distributes and partners with other reagents suppliers

Beyond the preview

Go deeper on Novatein Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novatein Biosciences.

Explore the full profile